Primary cultures of smooth muscle cells (SMC) derived from rat aorta release a phospholipase A2 activity into the culture medium. Phospholipase A2 activity was determined with [I -'4C]oleate-labelled Escherichiu coli as substrate. The enzyme has a neutral pH optimum and the activity is critically dependent on the free calcium concentration, with significant activity in the micromolar range of free calcium. Treatment of SMC with the p agonist salbutamol, forskolin or cholera toxin, which all activate adenylate cyclase and increase intracellular CAMP concentration, increase the release of phospholipase A2 activity in a dose-dependent manner. Likewise, the addition of the membrane-permeable CAMP analogues, (Sp)-adenosine 3',5'-[thiolphosphate and N6,0-2'-dibutyryladenosine 3',5'-phosphate, enhance the release of phospholipase A2 activity from SMC in a dosedependent manner. There is a lag period of about 4 h before a significant secretion of phospholipase A2 can be detected under basal, as well as under stimulated conditions. The forskolin analogue 1,9-dideoxyforskolin, which is inactive as a stimulator of adenylate cyclase, has no effect on phospholipase A2 secretion. Likewise, the potent vasoconstrictive peptide angiotensin I1 activates inositol phospholipid turnover in SMC, but has no effect on phospholipase A2 release. Pretreatment of SMC with actinomycin D or cycloheximide completely suppresses basal and CAMP-stimulated secretion of phospholipase A2 activity, thus demonstrating that transcription and protein synthesis are necessary for enzyme release.High levels of extracellular phospholipase A2 have been described in association with local and systemic inflammatory processes in animals and man (for review see [I]). A rich source of inflammatory phospholipase A2 is the ascitic fluid that can be elicited in the peritoneal cavity of rabbits [2] and which has been purified to homogeneity (31. A soluble phospholipase A2 has also been described and purified from synovial fluids of patients with rheumatoid arthritis [4, 51. Soluble phospholipase A2 is secreted extracellularly from rabbit and rat chondrocytes, as well as from human synovial cells in response to interleukin 1 [6 -91 and tumour necrosis factor[9], two potent inflammatory mediators. Furthermore, the release of phospholipase A2 activity has been described from rabbit peritoneal neutrophils in response to the chemotactic peptide Met-Leu-Phe [I 01, from resident mouse peritoneal macrophages in response to zymosan [ll] and from rat platelets on stimulation with thrombin [12]. Extracellular phospholipase A2 is proinflammatory and vasoactive, and mediates hyperemia and a marked inflammatory reaction when injected intracutaneously into rabbits [14]. The present report presents data demonstrating that SMC spontaneously Correspondence to J. Pfeilschifter,